FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Antin

Research Profile

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Stephen R Walsh; Marissa B Wilck; Elise Zablowsky; Ying Zhang; Aruna Acharyya; Joseph H Antin; Shringkhala Bajimaya; Raphael Dolin; David J Dominguez; David C Fisher; Lisa S Gagne; Heather Hill; Jane A Kleinjan; Alka Patel; Michael S Seaman; Kelly A Verrill; Lindsey R Baden
Safety and immunogenicity of modified vaccinia ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.
Hasanain Shikari; Joseph H Antin; Reza Dana
Ocular Graft-versus-Host Disease: A Review.
Sarah Nikiforow; Jerome Ritz; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Philippe Armand; Bhavjot Bindra; Bruce R Blazar; Brett Glotzbecker; Vincent T Ho; Haesook T Kim; John Koreth; Sean McDonough; Corey Cutler
Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Antin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stephen R Walsh; Marissa B Wilck; Elise Zablowsky; Ying Zhang; Aruna Acharyya; Joseph H Antin; Shringkhala Bajimaya; Raphael Dolin; David J Dominguez; David C Fisher; Lisa S Gagne; Heather Hill; Jane A Kleinjan; Alka Patel; Michael S Seaman; Kelly A Verrill; Lindsey R Baden
Safety and immunogenicity of modified vaccinia ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.
The Journal of infectious diseases 2013;207(12):1888-97.
2013: Hasanain Shikari; Joseph H Antin; Reza Dana
Ocular Graft-versus-Host Disease: A Review.
Survey of ophthalmology 2013;58(3):233-51.
2013: Sarah Nikiforow; Jerome Ritz; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Philippe Armand; Bhavjot Bindra; Bruce R Blazar; Brett Glotzbecker; Vincent T Ho; Haesook T Kim; John Koreth; Sean McDonough; Corey Cutler
Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(5):804-11.
2013: Ken-ichi Matsuoka; Sean McDonough; Kazuyuki Murase; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Philippe Armand; Gregory Bascug; Bruce R Blazar; Corey Cutler; Vincent T Ho; Yutaka Kawano; Haesook T Kim; John Koreth; Jerome Ritz
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.
Science translational medicine 2013;5(179):179ra43.
2013: Lee Gazourian; Vincent T Ho; Jerome Ritz; Angela J Rogers; Robert J Soiffer; Joseph H Antin; Rebecca M Baron; Anna Maria F Coronata; Gerald L Weinhouse; George R Washko
Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
Respiratory medicine 2013;107(2):276-83.
2013: Paul G Richardson; Joseph H Antin; Corey Cutler; B Glotzbecker; Vincent T Ho; Robert J Soiffer
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1 Suppl):S88-90.
2013: Philippe Armand; Corey Cutler; Vincent T Ho; Haesook T Kim; John Koreth; R Y Kwong; E J Neufeld; J Rhodes; M-M Sainvil; Robert J Soiffer; Edwin P Alyea; Joseph H Antin
Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT.
Bone marrow transplantation 2013;48(1):146-7.
2012: Karen Ballen; Vicki Boussiotis; Corey Cutler; Colleen Delaney; Bimalangshu R Dey; Vincent T Ho; Katarzyna Jamieson; Ram Kamble; John Koreth; Richard T Maziarz; Steven McAfee; Philip McCarthy; Adam M Mendizabal; Ioannis Politikos; Elizabeth J Shpall; Robert Soiffer; Thomas R Spitzer; John R Wingard; Edwin Alyea; Eyal C Attar; David Avigan; Edward D Ball; Joseph H Antin
Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(12):1851-8.
2012: Joshua A Hill; Vincent T Ho; Sophia Koo; John Koreth; Edwin P Alyea; Joseph H Antin; Philippe Armand; Lindsey R Baden; Corey Cutler; Belisa B Guzman Suarez; Robert J Soiffer; Francisco M Marty
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(11):1638-48.
2012: John Koreth; Sean M McDonough; Jerome Ritz; Robert J Soiffer; Kristen E Stevenson; Joseph H Antin; Philippe Armand; Bhavjot Bindra; Bruce R Blazar; Corey Cutler; Vincent T Ho; Haesook T Kim; Edwin P Alyea
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):3202-8.
2012: David W Kubiak; Joseph H Antin; Philippe Armand; Lindsey R Baden; Sarah P Hammond; Sophia Koo; Francisco M Marty
Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1462-5.
2012: Paul G Richardson; Nicole Stavitzski; Joseph H Antin; Sally Arai; Enric Carreras; Corey Cutler; Sergio Giralt; Vincent T Ho; Ernst Holler; Shin Mineishi; Dietger Niederwieser; Robert Soiffer
Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease.
Therapeutic advances in hematology 2012;3(4):253-65.
2012: Philippe Armand; Corey Cutler; H Joachim Deeg; Christopher J Gibson; Vincent T Ho; John Koreth; Stephanie J Lee; Jerome Ritz; Robert J Soiffer; Mohamed L Sorror; Barry E Storer; Edwin P Alyea; Joseph H Antin; Frederick R Appelbaum; Haesook T Kim
A disease risk index for patients undergoing allogeneic stem cell transplantation.
Blood 2012;120(4):905-13.
2012: Jakub Tolar; Roberta H Adams; Joseph H Antin; Sally Arai; Shelly L Carter; Dennis L Confer; H Joachim Deeg; Nancy L Difronzo; Mary Eapen; Marian Ewell; Iris D Gersten; Mary M Horowitz; Mitchell Horwitz; Eric S Leifer; John M McCarty; Ryotaro Nakamura; Michael Allen Pulsipher; Paolo Anderlini
Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(7):1007-11.
2012: Philippe Armand; Corey Cutler; Vincent T Ho; Haesook T Kim; John Koreth; Raymond Y Kwong; Ellis J Neufeld; Joanna Rhodes; Marie-Michele Sainvil; Robert J Soiffer; Edwin P Alyea; Joseph H Antin
Does iron overload really matter in stem cell transplantation?
American journal of hematology 2012;87(6):569-72.
2012: Yi-Bin Chen; Corey Cutler; Julie Aldridge; Edwin P Alyea; Joseph H Antin; Philippe Armand; Karen K Ballen; Greg Bourdeau; Grace Kao; Haesook T Kim; John Koreth; Deborah Liney; Jerome Ritz; Robert J Soiffer; Thomas R Spitzer; Vincent T Ho
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(5):805-12.
2012: Karim E Abou-Nassar; Edwin P Alyea; Joseph H Antin; Jeff Blossom; Corey Cutler; Vincent T Ho; Haesook T Kim; John Koreth; Robert J Soiffer; Philippe Armand
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(5):708-15.
2012: Caron A Jacobson; Grace S Kao; Haesook T Kim; John Koreth; Sean M McDonough; Carol G Reynolds; Robert J Soiffer; Kristen E Stevenson; Amin T Turki; Edwin P Alyea; Joseph H Antin; Philippe Armand; Karen K Ballen; Yi-Bin Chen; Corey Cutler; Maria I Herrera; Vincent T Ho; Jerome Ritz
Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(4):565-74.
2012: Bradley W Blaser; Corey Cutler; Vincent T Ho; Haesook T Kim; John Koreth; Jorge Plutzky; Edwin P Alyea; Joseph H Antin; Philippe Armand; Robert J Soiffer
Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(4):575-83.
2012: Mathangi Srinivasan; Patricia A Taylor; Joseph H Antin; Jeffrey L Browning; Ryan Flynn; Leo Luznik; William Murphy; Angela Panoskaltsis-Mortari; Andrew Price; Ann Ranger; Jerome Ritz; Mark J Shlomchik; Bruce R Blazar
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
Blood 2012;119(6):1570-80.
2012: Oliver Weigert; Akinori Yoda; Joseph H Antin; Anita Y Bahar; Bjoern Chapuy; Suzanne E Dahlberg; David C Fisher; Edward A Fox; Terry Haley; Nadja Kopp; Frank C Kuo; Jeffery L Kutok; Andrew A Lane; Janina A Longtine; Donna Neuberg; Scott J Rodig; Maura Salois; Timothy J Sullivan; David M Weinstock
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation.
Cancer discovery 2012;2(1):47-55.
2011: John Koreth; Ken-ichi Matsuoka; Sean M McDonough; Sashank Prasad; Jerome Ritz; Nathaniel S Treister; Dimitrios Tzachanis; Edwin P Alyea; Joseph H Antin; Philippe Armand; David Avigan; Don C Bienfang; Bhavjot Bindra; Corey Cutler; Vincent T Ho; Robin M Joyce; Haesook T Kim; Robert J Soiffer
Interleukin-2 and regulatory T cells in graft-versus-host disease.
The New England journal of medicine 2011;365(22):2055-66.
2011: K E Abou-Nassar; Edwin P Alyea; Joseph H Antin; Corey Cutler; D C Fisher; Vincent T Ho; Eric Jacobsen; John Koreth; Ann S LaCasce; K McDermott; Robert J Soiffer; K E Stevenson; A S Freedman
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.
Bone marrow transplantation 2011;46(12):1503-9.
2011: Yutaka Kawano; Haesook T Kim; John Koreth; Ken-Ichi Matsuoka; Sean McDonough; Edwin P Alyea; Joseph H Antin; Gregory Bascug; Corey Cutler; Vincent T Ho; Robert J Soiffer; Jerome Ritz
Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.
Blood 2011;118(18):5021-30.
2011: David A Jacobsohn; John P Klein; Thomas R Klumpp; Stephanie J Lee; Effie W Petersdorf; Stella Santarone; Harry C Schouten; Stephen R Spellman; Alvaro Urbano-Ispizua; Daniel J Weisdorf; John R Wingard; Joseph H Antin; Mukta Arora; Brian J Bolwell; Michael Boyiadzis; Jean-Yves Cahn; Mitchell S Cairo; Corey S Cutler; Mary E Flowers; Robert P Gale; Anna Hassebroek; Roger H Herzig; Mary M Horowitz; Luis M Isola; Steven Z Pavletic
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.
Blood 2011;118(16):4472-9.
2011: Alex F Herrera; Vincent T Ho; Jason L Hornick; Joseph H Antin; Lindsey R Baden; Karen K Ballen; Andrew M Bellizzi; Corey Cutler; Robert J Soiffer; Gabriela Soriano; Francisco M Marty
Cord colitis syndrome in cord-blood stem-cell transplantation.
The New England journal of medicine 2011;365(9):815-24.
2011: Matthew J Carty; Evan A Farkash; Julian J Pribaz; Christiana E Toomey; Elgida R Volpicelli; Joseph H Antin; Ephraim P Hochberg
A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast.
Plastic and reconstructive surgery 2011;128(3):112e-118e.
2011: Mary Eapen; Joseph Fay; Mary M Horowitz; Jennifer Le Rademacher; Judith C W Marsh; Jakob R Passweg; Jakub Tolar; Joseph H Antin; Jeanette Carreras; Richard E Champlin; H Joachim Deeg
Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.
Blood 2011;118(9):2618-21.
2011: Fabrice Porcheray; Jerome Ritz; Stefanie Sarantopoulos; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Roberto Bellucci; Blair H Floyd; David B Miklos; Emmanuel Zorn
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.
Transplantation 2011;92(3):359-65.
2011: Vincent T Ho; Grace Kao; Haesook T Kim; John Koreth; Deborah Liney; Jerome Ritz; Robert J Soiffer; Julie Aldridge; Joseph H Antin; Philippe Armand; Corey Cutler; Edwin P Alyea
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(8):1196-204.
2011: Mukta Arora; Brian J Bolwell; Michael Boyiadzis; Jean-Yves Cahn; Mitchell S Cairo; Corey S Cutler; Mary E D Flowers; Robert Peter Gale; Anna Hassebroek; Mary M Horowitz; Luis Isola; David A Jacobsohn; Madan Jagasia; John P Klein; Thomas R Klumpp; Stephanie J Lee; Effie W Petersdorf; Stella Santarone; Harry C Schouten; Stephen R Spellman; Alvaro Urbano-Ispizua; Daniel J Weisdorf; John R Wingard; Joseph H Antin; Steven Z Pavletic
Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.
Blood 2011;117(24):6714-20.
2011: Joseph H Antin
T-cell depletion in GVHD: less is more?
Blood 2011;117(23):6061-2.
2011: Philippe Armand; Haesook T Kim; Joanna Rhodes; Marie-Michele Sainvil; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Doreen Hearsey; Ellis J Neufeld; Mark D Fleming; Hanno Steen; Damon Anderson; Raymond Y Kwong; Robert J Soiffer; Joseph H Antin
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):852-60.
2011: Corey Cutler; K Stevenson; Haesook T Kim; J Brown; S McDonough; M Herrera; C Reynolds; Deborah Liney; Grace S Kao; Vincent T Ho; Philippe Armand; John Koreth; Edwin P Alyea; Bimalangshu R Dey; Eyal C Attar; Thomas R Spitzer; Vassiliki A Boussiotis; Jerome Ritz; Robert J Soiffer; Joseph H Antin; Karen K Ballen
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.
Bone marrow transplantation 2011;46(5):659-67.
2011: Michael Allen Pulsipher; Neal S Young; Jakub Tolar; Antonio M Risitano; H Joachim Deeg; Paolo Anderlini; Rodrigo Calado; Seiji Kojima; Mary Eapen; Richard Harris; Phillip Scheinberg; Sharon Savage; Jaroslaw P Maciejewski; Ramon V Tiu; Nancy DiFronzo; mary m horowitz; Joseph H Antin
Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):291-9.
2011: Nicolas C Issa; Francisco M Marty; Lisa S Gagne; Sophia Koo; Kelly A Verrill; Edwin P Alyea; Corey Cutler; John Koreth; Philippe Armand; Vincent T Ho; Joseph H Antin; Robert J Soiffer; Lindsey R Baden
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):434-8.
2011: John Koreth; Melinda Biernacki; Julie Aldridge; Haesook T Kim; Edwin P Alyea; Philippe Armand; Corey Cutler; Vincent T Ho; Catherine J Wu; Joseph H Antin; Robert J Soiffer
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):421-8.
2011: Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Whitney S Washel; Nazmim S Bhuiya; Corey S Cutler; Edwin P Alyea; Vincent T Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.
Blood 2011;117(7):2275-83.
2011: Joseph H Antin; Andrew E Aplin; Sheue-Yann Cheng; Vincent L Cryns; Michael R Emmert-Buck; Dengshun Wang
American journal of cancer research: editorial board (2011).
American journal of cancer research 2011;1(6):817-22.
2011: Francisco M Marty; Eva M Petschnigg; Sarah P Hammond; John E Ready; Vincent T Ho; Robert J Soiffer; Colm Magee; Danny A Milner; Joseph H Antin; Lindsey R Baden
Invasive fungal disease after remote inoculation in transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(1):e7-10.
2010: Stacy E F Melanson; Kristen Stevenson; Haesook Kim; Joseph H Antin; Michael H Court; Vincent T Ho; Jerome Ritz; Robert J Soiffer; Frank C Kuo; Janina A Longtine; Petr Jarolim
Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.
American journal of hematology 2010;85(12):967-71.
2010: Corey Cutler; Joseph H Antin
Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update.
Current opinion in hematology 2010;17(6):500-4.
2010: David Porter; Edwin P Alyea; Joseph H Antin; Marcos DeLima; Eli Estey; J H Frederik Falkenburg; Nancy Hardy; Nicolaus Kroeger; Jose Leis; John E Levine; David G Maloney; Karl Peggs; Jacob M Rowe; ALAN WAYNE; Sergio Giralt; Michael R Bishop; Koen van Besien
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(11):1467-503.
2010: Philippe Armand; Haesook T Kim; E Mayer; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy.
Bone marrow transplantation 2010;45(11):1611-7.
2010: Corey Cutler; Haesook T Kim; Shaké Ayanian; Gary Bradwin; Carolyn Revta; Julie Aldridge; Vincent T Ho; Edwin P Alyea; John Koreth; Philippe Armand; Robert J Soiffer; Jerome Ritz; Paul G Richardson; Joseph H Antin
Prediction of veno-occlusive disease using biomarkers of endothelial injury.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(8):1180-5.
2010: David I Marks; Tao Wang; Waleska S Pérez; Joseph H Antin; Edward A Copelan; Robert Peter Gale; Biju George; Vikas Gupta; Joerg Halter; H Jean Khoury; Thomas R Klumpp; Hillard M Lazarus; Victor A Lewis; Philip McCarthy; David A Rizzieri; Mitchell Sabloff; Jeff Szer; Martin S Tallman; Daniel J Weisdorf
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.
Blood 2010;116(3):366-74.
2010: Karen K Ballen; Corey Cutler; Beow Y Yeap; Steven McAfee; Bimalangshu R Dey; Eyal C Attar; Yi-Bin Chen; Richard L Haspel; Deborah Liney; John Koreth; Vincent T Ho; Edwin P Alyea; Robert J Soiffer; Thomas R Spitzer; Joseph H Antin
Donor-derived second hematologic malignancies after cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(7):1025-31.
2010: Paul G Richardson; Robert J Soiffer; Joseph H Antin; Hajime Uno; Zhezhen Jin; Joanne Kurtzberg; Paul L Martin; Gideon Steinbach; Karen F Murray; Georgia B Vogelsang; Allen R Chen; Amrita Krishnan; Nancy A Kernan; David Avigan; Thomas R Spitzer; Howard M Shulman; Donald N Di Salvo; Carolyn Revta; Diane Warren; Parisa Momtaz; Gary Bradwin; L J Wei; Massimo Iacobelli; George B McDonald; Eva C Guinan
Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(7):1005-17.
2010: John Koreth; Julie Aldridge; Haesook T Kim; Edwin P Alyea; Corey Cutler; Philippe Armand; Jerome Ritz; Joseph H Antin; Robert J Soiffer; Vincent T Ho
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(6):792-800.
2010: Julia A Brown; Kristen Stevenson; Haesook T Kim; Corey Cutler; Karen Ballen; Sean McDonough; Carol Reynolds; Maria Herrera; Deborah Liney; Vincent T Ho; Grace Kao; Philippe Armand; John Koreth; Edwin P Alyea; Steve McAfee; Eyal Attar; Bimalangshu R Dey; Thomas Spitzer; Robert J Soiffer; Jerome Ritz; Joseph H Antin; Vassiliki A Boussiotis
Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis.
Blood 2010;115(20):4111-9.
2010: Ken-ichi Matsuoka; Haesook T Kim; Sean McDonough; Gregory Bascug; Ben Warshauer; John Koreth; Corey Cutler; Vincent T Ho; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
The Journal of clinical investigation 2010;120(5):1479-93.
2010: John Koreth; Joseph H Antin
Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation.
Haematologica 2010;95(3):364-6.
2010: Yishai Ofran; Haesook T Kim; Vladimir Brusic; Loren Blake; Michael Mandrell; Catherine J Wu; Stefanie Sarantopoulos; Roberto Bellucci; Derin B Keskin; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(5):1642-51.
2010: Jason A Coppell; Paul G Richardson; Robert Soiffer; Paul L Martin; Nancy A Kernan; Allen R Chen; Eva Guinan; Georgia B Vogelsang; Amrita Krishnan; Sergio Giralt; Carolyn Revta; Nicole A Carreau; Massimo Iacobelli; Enric Carreras; Tapani Ruutu; Tiziano Barbui; Joseph H Antin; Dietger Niederwieser
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(2):157-68.
2010: Grace Chang; Mary-Ellen Meadows; Jennifer A Jones; Joseph H Antin; E John Orav
Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS).
The American journal of drug and alcohol abuse 2010;36(1):1-6.
2010: Rainer Storb; Joseph H Antin; Corey Cutler
Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1 Suppl):S18-27.
2009: Steven A McCarroll; James E Bradner; Hannu Turpeinen; Liisa Volin; Paul J Martin; Shannon D Chilewski; Joseph H Antin; Stephanie J Lee; Tapani Ruutu; Barry Storer; Edus H Warren; Bo Zhang; Lue Ping Zhao; David Ginsburg; Robert J Soiffer; Jukka Partanen; John A Hansen; Jerome Ritz; Aarno Palotie; David Altshuler
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.
Nature genetics 2009;41(12):1341-4.
2009: Daniel J Weisdorf; Gene Nelson; Stephanie J Lee; Michael Haagenson; Stephen R Spellman; Joseph H Antin; Brian J Bolwell; Jean-Yves Cahn; Francisco Cervantes; Edward A Copelan; Robert Gale; Alois Gratwohl; H Jean Khoury; Philip McCarthy; David I Marks; Jeff Szer; Ann Woolfrey; Jorge Cortes-Franco; Mary M Horowitz; Mukta Arora
Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1475-8.
2009: John Koreth; Kristen E Stevenson; Haesook T Kim; Michael Garcia; Vincent T Ho; Philippe Armand; Corey Cutler; Jerome Ritz; Joseph H Antin; Robert J Soiffer; Edwin P Alyea
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Blood 2009;114(18):3956-9.
2009: Grace Chang; Mary-Ellen Meadows; E John Orav; Joseph H Antin
Mental status changes after hematopoietic stem cell transplantation.
Cancer 2009;115(19):4625-35.
2009: Vincent T Ho; Matthew Vanneman; Haesook Kim; Tetsuro Sasada; Yoon-Joong Kang; Mildred Pasek; Corey Cutler; John Koreth; Edwin P Alyea; Stefanie Sarantopoulos; Joseph H Antin; Jerome Ritz; Christine Canning; Jeffery Kutok; Martin C Mihm; Glenn Dranoff; Robert J Soiffer
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(37):15825-30.
2009: Yi-Bin Chen; Haesook T Kim; Sean McDonough; Robert D Odze; Xiaopan Yao; Suzan Lazo-Kallanian; Thomas R Spitzer; Robert Soiffer; Joseph H Antin; Jerome Ritz
Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1066-76.
2009: Vincent T Ho; Julie Aldridge; Haesook T Kim; Corey Cutler; John Koreth; Philippe Armand; Joseph H Antin; Robert J Soiffer; Edwin P Alyea
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):844-50.
2009: John Koreth; Richard Schlenk; Kenneth J Kopecky; Sumihisa Honda; Jorge Sierra; Benjamin Djulbegovic; Martha Wadleigh; Daniel J DeAngelo; Richard M Stone; Hisashi Sakamaki; Frederick R Appelbaum; Hartmut Döhner; Joseph H Antin; Robert J Soiffer; Corey Cutler
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
JAMA : the journal of the American Medical Association 2009;301(22):2349-61.
2009: Meghan Delaney; Corey S Cutler; Richard L Haspel; Beow Y Yeap; Steven L McAfee; Bimalangshu R Dey; Eyal Attar; Grace Kao; Edwin P Alyea; John Koreth; Vincent T Ho; Susan Saidman; Deborah Liney; Doreen Sese; Robert J Soiffer; Thomas R Spitzer; Joseph H Antin; Karen K Ballen
High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
Transfusion 2009;49(5):995-1002.
2009: Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Corey Cutler; Nazmim S Bhuiya; Michael Schowalter; Vincent T Ho; Edwin P Alyea; John Koreth; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
Blood 2009;113(16):3865-74.
2009: Mukta Arora; Daniel J Weisdorf; Stephen R Spellman; Michael D Haagenson; John P Klein; Carolyn K Hurley; George B Selby; Joseph H Antin; Nancy A Kernan; Craig Kollman; Auayporn Nademanee; Philip McGlave; Mary M Horowitz; Effie W Petersdorf
HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(10):1644-52.
2009: Denise M Oliansky; Joseph H Antin; john bennett; H Joachim Deeg; Christin Engelhardt; Kathleen V Heptinstall; Marcos de Lima; Steven D Gore; Ronald G Potts; Lewis R Silverman; Roy B Jones; Philip L McCarthy; Theresa Hahn
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(2):137-72.
2009: Robert Korngold; Joseph H Antin
Biology and management of acute graft-versus-host disease.
Cancer treatment and research 2009;144():257-75.
2008: Philippe Armand; Supriya Gannamaneni; Haesook T Kim; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Ann S LaCasce; Eric D Jacobsen; David C Fisher; Jennifer R Brown; George P Canellos; Arnold S Freedman; Robert J Soiffer; Joseph H Antin
Improved survival in lymphoma patients receiving sirolimus for graft-versus-host disease prophylaxis after allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5767-74.
2008: Corey Cutler; Kristen Stevenson; Haesook T Kim; Paul Richardson; Vincent T Ho; Erica Linden; Carolyn Revta; Ruth Ebert; Diane Warren; Sung Won Choi; John Koreth; Philippe Armand; Edwin P Alyea; Shelly Carter; Mary Horowitz; Joseph H Antin; Robert J Soiffer
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
Blood 2008;112(12):4425-31.
2008: Gregory Yanik; Vincent T Ho; John E Levine; Eric White; Thomas Braun; Joseph H Antin; Joel Whitfield; Joseph R Custer; Dawn Jones; James L M Ferrara; Kenneth R Cooke
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
Blood 2008;112(8):3073-81.
2008: John Koreth; Joseph H Antin
Current and future approaches for control of graft-versus-host disease.
Expert review of hematology 2008;1(1):111.
2008: Paul Armistead; Mehrdad Mohseni; Roslyn Gerwin; Emily C Walsh; Masoud Iravani; Bahram Chahardouli; Shahrbano Rostami; Wandi Zhang; Donna Neuberg; John Rioux; Ardeshir Ghavamzadeh; Jerome Ritz; Joseph H Antin; Catherine J Wu
Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation.
Experimental hematology 2008;36(9):1205-15.
2008: Edwin P Alyea; Shuli Li; Haesook T Kim; Corey Cutler; Vincent T Ho; Robert J Soiffer; Joseph H Antin
Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):920-6.
2008: Philippe Armand; Haesook T Kim; Vincent T Ho; Corey Cutler; John Koreth; Joseph H Antin; Ann S LaCasce; Eric Jacobsen; David C Fisher; Jennifer R Brown; George P Canellos; Arnold S Freedman; Robert J Soiffer; Edwin P Alyea
Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(4):418-25.
2008: R L Haspel; Grace S Kao; B Y Yeap; Corey Cutler; Robert J Soiffer; Edwin P Alyea; Vincent T Ho; John Koreth; B R Dey; S L McAfee; E C Attar; T Spitzer; Joseph H Antin; K K Ballen
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.
Bone marrow transplantation 2008;41(6):523-9.
2008: Akiko M Saito; Corey Cutler; David Zahrieh; Robert J Soiffer; Vincent T Ho; Edwin P Alyea; John Koreth; Joseph H Antin; Stephanie J Lee
Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):197-207.
2008: Richard F Schlenk; Marcelo C Pasquini; Waleska S Pérez; Mei-Jie Zhang; Jürgen Krauter; Joseph H Antin; Asad Bashey; Brian J Bolwell; Thomas Büchner; Jean-Yves Cahn; Mitchell S Cairo; Edward A Copelan; Corey Cutler; Hartmut Döhner; Robert Peter Gale; Osman Ilhan; Hillard M Lazarus; Jane L Liesveld; Mark R Litzow; David I Marks; Richard T Maziarz; Philip L McCarthy; Stephen D Nimer; Jorge Sierra; Martin S Tallman; Daniel J Weisdorf; Mary M Horowitz; Arnold Ganser
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):187-96.
2008: Corey Cutler; Joseph H Antin
Novel drugs for the prevention and treatment of acute GVHD.
Current pharmaceutical design 2008;14(20):1962-73.
2008: Nathaniel S Treister; E Francis Cook; Joseph H Antin; Stephanie J Lee; Robert J Soiffer; Sook-Bin Woo
Clinical evaluation of oral chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):110-5.
2008: Philippe Armand; Haesook T Kim; Corey Cutler; Vincent T Ho; John Koreth; Jerome Ritz; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):28-35.
2007: James L M Ferrara; Claudio Anasetti; Edward Stadtmauer; Joseph H Antin; John Wingard; Stephanie Lee; John E Levine; Kirk R Schultz; Frederick Appelbaum; Robert Negrin; Sergio Giralt; Christopher N Bredeson; Helen Heslop; Mary Horowitz
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1268-85.
2007: Catherine J Wu; Mark Gladwin; John Tisdale; Matthew Hsieh; Terence Law; Melinda Biernacki; Shelby Rogers; Xunde Wang; Mark Walters; David Zahrieh; Joseph H Antin; Jerome Ritz; Lakshamanan Krishnamurti
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
British journal of haematology 2007;139(3):504-7.
2007: Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Nazmim S Bhuiya; Corey Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz
High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6107-14.
2007: A M Saito; David Zahrieh; Corey Cutler; Vincent T Ho; Joseph H Antin; Robert J Soiffer; Edwin P Alyea; Stephanie J Lee
Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy.
Bone marrow transplantation 2007;40(3):209-17.
2007: Francisco M Marty; Julie Bryar; Sarah K Browne; Talya Schwarzberg; Vincent T Ho; Ingrid Valerie Bassett; John Koreth; Edwin P Alyea; Robert J Soiffer; Corey Cutler; Joseph H Antin; Lindsey R Baden
Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis.
Blood 2007;110(2):490-500.
2007: W W Seeley; Francisco M Marty; T M Holmes; K Upchurch; Robert J Soiffer; Joseph H Antin; Lindsey R Baden; E B Bromfield
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.
Neurology 2007;69(2):156-65.
2007: Karen K Ballen; Elizabeth J Shpall; David Avigan; Beow Y Yeap; David C Fisher; Kathleen McDermott; Bimalangshu R Dey; Eyal C Attar; Steven McAfee; Marina Konopleva; Joseph H Antin; Thomas R Spitzer
Phase I trial of parathyroid hormone to facilitate stem cell mobilization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(7):838-43.
2007: Philippe Armand; Haesook T Kim; Daniel J DeAngelo; Vincent T Ho; Corey Cutler; Richard M Stone; Jerome Ritz; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):655-64.
2007: Philippe Armand; Haesook T Kim; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Robert J Soiffer; Joseph H Antin
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.
Blood 2007;109(10):4586-8.
2007: Philippe Armand; Joseph H Antin
Allogeneic stem cell transplantation for aplastic anemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):505-16.
2007: Corey Cutler; Shuli Li; Vincent T Ho; John Koreth; Edwin P Alyea; Robert J Soiffer; Joseph H Antin
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.
Blood 2007;109(7):3108-14.
2007: Joseph H Antin
Reduced-Intensity Stem Cell Transplantation: "...whereof a little More than a little is by much too much." King Henry IV, part 1, I, 2.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2007;():47-54.
2007: Karen K Ballen; Thomas R Spitzer; Beow Y Yeap; Steven McAfee; Bimalangshu R Dey; Eyal C Attar; Richard Haspel; Grace S Kao; Deborah Liney; Edwin P Alyea; Stephanie Lee; Corey Cutler; Vincent T Ho; Robert J Soiffer; Joseph H Antin
Double unrelated reduced-intensity umbilical cord blood transplantation in adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(1):82-9.
2006: Jennifer R Brown; Haesook T Kim; Shuli Li; Katherine Stephans; David C Fisher; Corey Cutler; Vincent T Ho; Stephanie J Lee; Edgar L Milford; Jerome Ritz; Joseph H Antin; Robert J Soiffer; John G Gribben; Edwin P Alyea
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1056-64.
2006: Edwin P Alyea; Haesook T Kim; Vincent T Ho; Corey Cutler; Daniel J DeAngelo; Richard M Stone; Jerome Ritz; Joseph H Antin; Robert J Soiffer
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1047-55.
2006: Corey Cutler; Joseph H Antin
The role of allogeneic stem cell transplantation for CML in the tyrosine kinase inhibitor era.
Current hematologic malignancy reports 2006;1(3):160-7.
2006: Benjamin D Humphreys; Vijay K Vanguri; Joel Henderson; Joseph H Antin
Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient.
Nature clinical practice. Nephrology 2006;2(9):535-9; quiz 540.
2006: Stephanie J Lee; Haesook T Kim; Vincent T Ho; Corey Cutler; Edwin P Alyea; Robert J Soiffer; Joseph H Antin
Quality of life associated with acute and chronic graft-versus-host disease.
Bone marrow transplantation 2006;38(4):305-10.
2006: Corey Cutler; David B Miklos; Haesook T Kim; Nathaniel S Treister; Sook-Bin Woo; Don Bienfang; Lloyd B Klickstein; Jesse Levin; Katherine Miller; Carol Reynolds; Rebecca Macdonell; Mildred Pasek; Stephanie J Lee; Vincent T Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Edwin P Alyea
Rituximab for steroid-refractory chronic graft-versus-host disease.
Blood 2006;108(2):756-62.
2006: Francisco M Marty; Colleen M Lowry; Corey Cutler; Bonnie J Campbell; Karen Fiumara; Lindsey R Baden; Joseph H Antin
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):552-9.
2006: Vincent T Ho; Haesook T Kim; Deborah Liney; Edgar L Milford; John G Gribben; Corey Cutler; Stephanie J Lee; Joseph H Antin; Robert J Soiffer; Edwin P Alyea
HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.
Bone marrow transplantation 2006;37(9):845-50.
2006: Corey Cutler; Joseph H Antin
Chronic graft-versus-host disease.
Current opinion in oncology 2006;18(2):126-31.
2006: David Porter; Joseph H Antin
Donor leukocyte infusions in myeloid malignancies: new strategies.
Best practice & research. Clinical haematology 2006;19(4):737-55.
2006: H Joachim Deeg; Joseph H Antin
The clinical spectrum of acute graft-versus-host disease.
Seminars in hematology 2006;43(1):24-31.
2005: Joseph H Antin
Approaches to graft-vs-host disease.
Pediatric transplantation 2005;9 Suppl 7():71-5.
2005: Corey Cutler; Joseph H Antin
An overview of hematopoietic stem cell transplantation.
Clinics in chest medicine 2005;26(4):517-27, v.
2005: Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Evidence for ineffective erythropoiesis in severe sickle cell disease.
Blood 2005;106(10):3639-45.
2005: Emmanuel Zorn; Haesook T Kim; Stephanie J Lee; Blair H Floyd; Despina Litsa; Sankari Arumugarajah; Roberto Bellucci; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
Blood 2005;106(8):2903-11.
2005: Jean-Yves Cahn; John P Klein; Su-Jun Lee; Noël Milpied; Didier Blaise; Joseph H Antin; Véronique Leblond; Norbert Ifrah; Jean-Pierre Jouet; Fausto R Loberiza; Olle Ringden; A John Barrett; Mary M Horowitz; Gérard Socié
Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study.
Blood 2005;106(4):1495-500.
2005: Corey Cutler; N Lynn Henry; Colm Magee; Shuli Li; Haesook T Kim; Edwin P Alyea; Vincent T Ho; Stephanie J Lee; Robert J Soiffer; Joseph H Antin
Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):551-7.
2005: Joseph H Antin
Donor leukocyte infusions and graft-versus-malignancy.
Journal of clinical apheresis 2005;20(2):113-6.
2005: Corey Cutler; Shuli Li; Haesook T Kim; Patricia Laglenne; Kwok Chuen Szeto; Laura Hoffmeister; M Joel Harrison; Vincent T Ho; Edwin P Alyea; Stephanie J Lee; Robert J Soiffer; Stephen Sonis; Joseph H Antin
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):383-8.
2005: David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent T Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.
Blood 2005;105(7):2973-8.
2005: Joseph H Antin; Eva C Guinan; David Avigan; Robert J Soiffer; Robin M Joyce; Victoria J Martin; Deborah C Molrine
Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):213-22.
2005: Brock A Peters; Luis Alberto Diaz; Kornelia Polyak; Leslie Meszler; Katharine E Romans; Eva C Guinan; Joseph H Antin; David Myerson; Stanley R Hamilton; Bert Vogelstein; Kenneth W Kinzler; Christoph Lengauer
Contribution of bone marrow-derived endothelial cells to human tumor vasculature.
Nature medicine 2005;11(3):261-2.
2005: Hakumei Oh; Fausto R Loberiza; Mei-Jie Zhang; Olle Ringdén; Hideki Akiyama; Takayoshi Asai; Shuichi Miyawaki; Shinichiro Okamoto; Mary M Horowitz; Joseph H Antin; Asad Bashey; Jennifer M Bird; Matthew H Carabasi; Joseph W Fay; Robert Peter Gale; Roger H Giller; John M Goldman; gregory alan hale; Richard E Harris; Jean Henslee-Downey; Hans-Jochem Kolb; Mark R Litzow; Philip L McCarthy; Steven M Neudorf; Derek S Serna; Gérard Socié; Pierre Tiberghien; A John Barrett
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
Blood 2005;105(4):1408-16.
2005: Edwin P Alyea; Haesook T Kim; Vincent T Ho; Corey Cutler; John G Gribben; Daniel J DeAngelo; Stephanie J Lee; Sarah Windawi; Jerome Ritz; Richard M Stone; Joseph H Antin; Robert J Soiffer
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.
Blood 2005;105(4):1810-4.
2005: Joseph H Antin
Immune reconstitution: the major barrier to successful stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2 Suppl 2):43-5.
2005: F Stephen Hodi; Scott R Granter; Joseph H Antin
Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report.
Cancer immunity 2005;5():7.
2005: Grace Chang; E John Orav; Tay K McNamara; Mei-Yee Tong; Joseph H Antin
Psychosocial function after hematopoietic stem cell transplantation.
Psychosomatics 2005;46(1):34-40.
2005: Stephanie J Lee; Fausto R Loberiza; Joseph H Antin; T Kirkpatrick; L Prokop; Edwin P Alyea; Corey Cutler; Vincent T Ho; Paul G Richardson; Robert Schlossman; David C Fisher; B Logan; Robert J Soiffer
Routine screening for psychosocial distress following hematopoietic stem cell transplantation.
Bone marrow transplantation 2005;35(1):77-83.
2004: Noopur Raje; Shaji Kumar; Teru Hideshima; Kenji Ishitsuka; Dharminder Chauhan; Constantine S Mitsiades; klaus podar; Steven Le Gouill; Paul Richardson; Nikhil C Munshi; David I Stirling; Joseph H Antin; Kenneth C Anderson
Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma.
Blood 2004;104(13):4188-93.
2004: Vincent T Ho; Haesook T Kim; Sigui Li; Ephraim P Hochberg; Corey Cutler; Stephanie J Lee; David C Fisher; Edgar L Milford; Grace S Kao; Heather Daley; Jesse Levin; Andrea K Ng; Peter M Mauch; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.
Bone marrow transplantation 2004;34(11):987-94.
2004: Joseph H Antin; Allen R Chen; Daniel Couriel; Vincent T Ho; Richard A Nash; Daniel Weisdorf
Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):655-68.
2004: Corey Cutler; Joseph H Antin
Mammalian target of rapamycin inhibition as therapy for hematologic malignancies.
Cancer 2004;101(6):1478; author reply 1478.
2004: Grace Chang; E John Orav; Mei-Yee Tong; Joseph H Antin
Predictors of 1-year survival assessed at the time of bone marrow transplantation.
Psychosomatics 2004;45(5):378-85.
2004: Corey Cutler; Joseph H Antin
Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation.
Bone marrow transplantation 2004;34(6):471-6.
2004: Stephanie J Lee; David Zahrieh; Edward Agura; Margaret L MacMillan; Richard T Maziarz; Philip L McCarthy; Vincent T Ho; Corey Cutler; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.
Blood 2004;104(5):1559-64.
2004: Grace Chang; E John Orav; Tay K McNamara; Mei-Yee Tong; Joseph H Antin
Depression, cigarette smoking, and hematopoietic stem cell transplantation outcome.
Cancer 2004;101(4):782-9.
2004: Vincent T Ho; David Zahrieh; Ephraim P Hochberg; Eileen Micale; Jesse Levin; Carol Reynolds; Steve Steckel; Corey Cutler; David C Fisher; Stephanie J Lee; Edwin P Alyea; Jerome Ritz; Robert J Soiffer; Joseph H Antin
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(4):1224-6.
2004: Daniel J DeAngelo; Ephraim P Hochberg; Edwin P Alyea; Janina Longtine; Stephanie Lee; Ilene Galinsky; Ben Parekkedon; Jerome Ritz; Joseph H Antin; Richard M Stone; Robert J Soiffer
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5065-71.
2004: Corey Cutler; Su-Jun Lee; Peter Greenberg; H Joachim Deeg; Waleska S Pérez; Claudio Anasetti; Brian J Bolwell; Mitchell S Cairo; Robert Peter Gale; John P Klein; Hillard M Lazarus; Jane L Liesveld; Philip L McCarthy; Gustavo A Milone; J Douglas Rizzo; Kirk R Schultz; Michael E Trigg; Armand Keating; Daniel J Weisdorf; Joseph H Antin; Mary M Horowitz
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.
Blood 2004;104(2):579-85.
2004: Corey Cutler; Haesook T Kim; Ephraim P Hochberg; Vincent T Ho; Edwin P Alyea; Stephanie J Lee; David C Fisher; David B Miklos; Jesse Levin; Stephen Sonis; Robert J Soiffer; Joseph H Antin
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):328-36.
2004: Emmanuel Zorn; David B Miklos; Blair H Floyd; Alex Mattes-Ritz; Luxuan Guo; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation.
The Journal of experimental medicine 2004;199(8):1133-42.
2004: Zubair Abba; David Zahrieh; Heather Daley; Daryls Schott; John G Gribben; Edwin P Alyea; Robert Schlossman; Arnold S Freedman; Joseph H Antin; Robert J Soiffer; Donna Neuberg; Jerome Ritz
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy.
Transfusion 2004;44(2):253-61.
2004: Mirjana Milinkovic; Joseph H Antin; Charles A Hergrueter; Charles B Underhill; Robert Sackstein
CD44-hyaluronic acid interactions mediate shear-resistant binding of lymphocytes to dermal endothelium in acute cutaneous GVHD.
Blood 2004;103(2):740-2.
2004: David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.
Blood 2004;103(1):353-9.
2003: Lisa B Spiryda; Marc R Laufer; Robert J Soiffer; Joseph H Antin
Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(12):760-5.
2003: Joseph H Antin
Stem cell transplantation-harnessing of graft-versus-malignancy.
Current opinion in hematology 2003;10(6):440-4.
2003: Francisco M Marty; Stephanie J Lee; Michelle M Fahey; Edwin P Alyea; Robert J Soiffer; Joseph H Antin; Lindsey R Baden
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.
Blood 2003;102(8):2768-76.
2003: Martha Wadleigh; Paul G Richardson; David Zahrieh; Stephanie J Lee; Corey Cutler; Vincent T Ho; Edwin P Alyea; Joseph H Antin; Richard M Stone; Robert J Soiffer; Daniel J DeAngelo
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation.
Blood 2003;102(5):1578-82.
2003: Joseph H Antin; Haesook T Kim; Corey Cutler; Vincent T Ho; Stephanie J Lee; David B Miklos; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Robert J Soiffer
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.
Blood 2003;102(5):1601-5.
2003: Joseph H Antin
A 41-year-old woman with chronic myelogenous leukemia.
JAMA : the journal of the American Medical Association 2003;290(8):1083-90.
2003: Gorgun Akpek; Stephanie J Lee; Mary E D Flowers; Steven Z Pavletic; Mukta Arora; Shing Lee; Steven Piantadosi; Katherine A Guthrie; James C Lynch; Alessandra Takatu; Mary M Horowitz; Joseph H Antin; Daniel J Weisdorf; Paul J Martin; Georgia B Vogelsang
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.
Blood 2003;102(3):802-9.
2003: Stephanie J Lee; Fausto R Loberiza; J Douglas Rizzo; Robert J Soiffer; Joseph H Antin; Jane C Weeks
Optimistic expectations and survival after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(6):389-96.
2003: Deborah C Molrine; Joseph H Antin; Eva C Guinan; Robert J Soiffer; Kristin MacDonald; Richard Malley; Frank J Malinoski; Susan M Trocciola; Marjorie Wilson; Donna M Ambrosino
Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation.
Blood 2003;101(3):831-6.
2003: Grace Chang; Carol McGarigle; Danielle Koby; Joseph H Antin
Symptoms of pain and depression in related marrow donors: changes after transplant.
Psychosomatics 2003;44(1):59-64.
2003: Ephraim P Hochberg; David B Miklos; Donna Neuberg; Daniel A Eichner; Stephen F McLaughlin; Alex Mattes-Ritz; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation.
Blood 2003;101(1):363-9.
2002: Mark J DiNubile; Thomas P Stossel; Olof C Ljunghusen; James L M Ferrara; Joseph H Antin
Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation.
Blood 2002;100(13):4367-71.
2002: Paul G Richardson; Carol Murakami; Zhezhen Jin; Diane Warren; Parisa Momtaz; Deborah Hoppensteadt; Anthony D Elias; Joseph H Antin; Robert J Soiffer; Thomas R Spitzer; David Avigan; Scott I Bearman; Paul L Martin; Joanne Kurtzberg; James J Vredenburgh; Allen R Chen; Sally Arai; Georgia B Vogelsang; George B McDonald; Eva C Guinan
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.
Blood 2002;100(13):4337-43.
2002: Joseph H Antin; Daniel Weisdorf; Donna Neuberg; Roberta Nicklow; Shawn Clouthier; Stephanie J Lee; Edwin P Alyea; Carol McGarigle; Bruce R Blazar; Stephen Sonis; Robert J Soiffer; James L M Ferrara
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.
Blood 2002;100(10):3479-82.
2002: Stephanie J Lee; David Zahrieh; Edwin P Alyea; Edie Weller; Vincent T Ho; Joseph H Antin; Robert J Soiffer
Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs.
Blood 2002;100(8):2697-702.
2002: Thomas S Lin; David Zahrieh; Edie Weller; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Transplantation 2002;74(1):49-54.
2002: Su-Jun Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; gregory alan hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.
Blood 2002;100(2):406-14.
2002: Joseph H Antin
Clinical practice. Long-term care after hematopoietic-cell transplantation in adults.
The New England journal of medicine 2002;347(1):36-42.
2002: Fausto R Loberiza; J Douglas Rizzo; Christopher N Bredeson; Joseph H Antin; Mary M Horowitz; Jane C Weeks; Su-Jun Lee
Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2118-26.
2002: Daniel J Weisdorf; Claudio Anasetti; Joseph H Antin; Nancy A Kernan; Craig Kollman; David Snyder; Effie W Petersdorf; Gene Nelson; Philip B McGlave
Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
Blood 2002;99(6):1971-7.
2002: Joseph H Antin; Stephanie J Lee; Donna Neuberg; Edwin P Alyea; Robert J Soiffer; Stephen Sonis; James L M Ferrara
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.
Bone marrow transplantation 2002;29(5):373-7.
2002: Robert J Soiffer; Edwin P Alyea; Ephraim P Hochberg; Catherine Wu; Christine Canning; Bijal Parikh; David Zahrieh; Iain Webb; Joseph H Antin; Jerome Ritz
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(11):625-32.
2002: Edwin P Alyea; Edie Weller; David C Fisher; Arnold S Freedman; John G Gribben; Stephanie Lee; Robert Schlossman; Richard M Stone; Jonathan W Friedberg; Daniel J DeAngelo; Deborah Liney; Sarah Windawi; Andrea K Ng; Peter M Mauch; Joseph H Antin; Robert J Soiffer
Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(11):601-7.
2002: Stephanie k Lee; E Francis Cook; Robert J Soiffer; Joseph H Antin
Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(8):444-52.
2002: Paul J Martin; Joseph H Antin; Daniel J Weisdorf; Virginia Paton; Mary M Horowitz
Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(6):295-302.
2002: Stephanie J Lee; Georgia B Vogelsang; Andrew Gilman; Daniel J Weisdorf; Steven Z Pavletic; Joseph H Antin; Mary M Horowitz; Gorgun Akpek; Mary E D Flowers; Daniel Couriel; Paul J Martin
A survey of diagnosis, management, and grading of chronic GVHD.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(1):32-9.
2001: Su-Jun Lee; John P Klein; Claudio Anasetti; Joseph H Antin; Fausto R Loberiza; Brian J Bolwell; Charles F LeMaistre; Mark R Litzow; D Marks; Edmond WALLER; M Matlack; Sergio Giralt; Mary M Horowitz
The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.
Blood 2001;98(12):3205-11.
2001: Craig Kollman; C W Howe; Claudio Anasetti; Joseph H Antin; Stella M Davies; Alexandra H Filipovich; Janet Hegland; Naynesh Kamani; Nancy A Kernan; Roberta King; Voravit Ratanatharathorn; Daniel Weisdorf; Dennis L Confer
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.
Blood 2001;98(7):2043-51.
2001: Corey Cutler; Satyendra Giri; S Jeyapalan; D Paniagua; Akila N Viswanathan; Joseph H Antin
Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(16):3685-91.
2001: Drew J Winston; Joseph H Antin; Steven Neil Wolff; B E Bierer; Trudy N Small; K B Miller; Charles Linker; H Kaizer; Hillard M Lazarus; Finn Bo Petersen; M J Cowan; WG Ho; John R Wingard; Gary J Schiller; Mary Territo; J Jiao; M A Petrarca; S A Tonetta
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Bone marrow transplantation 2001;28(2):187-96.
2001: Joseph H Antin
Acute graft-versus-host disease: inflammation run amok?
The Journal of clinical investigation 2001;107(12):1497-8.
2001: Stephanie J Lee; DL Fairclough; Joseph H Antin; Jane C Weeks
Discrepancies between patient and physician estimates for the success of stem cell transplantation.
JAMA : the journal of the American Medical Association 2001;285(8):1034-8.
2001: Robert J Soiffer; Edie Weller; Edwin P Alyea; Peter M Mauch; I L Webb; David C Fisher; Arnold S Freedman; Robert Schlossman; John G Gribben; Sandra Lee; Kenneth C Anderson; Karen Marcus; Richard M Stone; Joseph H Antin; Jerome Ritz
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1152-9.
2001: C Wheeler; A Khurshid; Joseph G Ibrahim; A Elias; Peter M Mauch; K Ault; Joseph H Antin
Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Leukemia & lymphoma 2001;40(5-6):499-509.
2001: Joseph H Antin; R Childs; Alexandra H Filipovich; Sergio Giralt; S Mackinnon; Thomas R Spitzer; Daniel Weisdorf
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(9):473-85.
2001: David Porter; Selina M Luger; Kathleen M Duffy; Edward A Stadtmauer; Ginna G Laport; Stephen J Schuster; G Orloff; Donald Tsai; Kevin McDaid; A Kathakali; Debra G B Leonard; Joseph H Antin
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(4):230-8.
2001: Vincent T Ho; Edie Weller; Stephanie J Lee; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(4):223-9.
2001: Corey Cutler; Joseph H Antin
Peripheral blood stem cells for allogeneic transplantation: a review.
Stem cells (Dayton, Ohio) 2001;19(2):108-17.
2001: Stephanie J Lee; DL Fairclough; Susan K Parsons; Robert J Soiffer; David C Fisher; Robert Schlossman; Joseph H Antin; Jane C Weeks
Recovery after stem-cell transplantation for hematologic diseases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):242-52.
2000: Stella M Davies; Craig Kollman; Claudio Anasetti; Joseph H Antin; James L Gajewski; James T Casper; Auayporn Nademanee; Harriet Noreen; R King; Dennis L Confer; Nancy A Kernan
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program.
Blood 2000;96(13):4096-102.
2000: Richard A Nash; Joseph H Antin; Chatchada Karanes; Joseph W Fay; Belinda R Avalos; A M Yeager; Donna Przepiorka; S Davies; F B Petersen; P Bartels; Donald N Buell; William E Fitzsimmons; Claudio Anasetti; Rainer Storb; Voravit Ratanatharathorn
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Blood 2000;96(6):2062-8.
2000: Philip B McGlave; X O Shu; W Wen; C Anasetti; Auayporn Nademanee; R Champlin; Joseph H Antin; Nancy A Kernan; R King; D J Weisdorf
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program.
Blood 2000;95(7):2219-25.
2000: David Porter; Robert H Collins; Christine Hardy; Nancy A Kernan; William R Drobyski; Sergio Giralt; M E Flowers; James T Casper; A Leahey; P Parker; Rosemarie Mick; B Bate-Boyle; R King; Joseph H Antin
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions.
Blood 2000;95(4):1214-21.
2000: M J Vasconcelles; M V Bernardo; C King; E A Weller; Joseph H Antin
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):35-43.
2000: Stephanie J Lee; Neil Klar; Jane C Weeks; Joseph H Antin
Predicting costs of stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):64-71.
1999: Richard J Benjamin; Joseph H Antin
ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity.
Transfusion 1999;39(11-12):1273-4.
1999: David Porter; J M Connors; Vivianna M Van Deerlin; Kathleen M Duffy; C McGarigle; S L Saidman; Debra G B Leonard; Joseph H Antin
Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1234.
1999: L H Sehn; Edwin P Alyea; Edie Weller; Christine Canning; Sandra Lee; Jerome Ritz; Joseph H Antin; Robert J Soiffer
Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):561-8.
1999: Richard J Benjamin; Siobhan McGurk; M S Ralston; Winthrop H Churchill; Joseph H Antin
ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation.
Transfusion 1999;39(2):179-87.
1999: David Porter; Robert H Collins; O Shpilberg; William R Drobyski; J M Connors; A Sproles; Joseph H Antin
Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(4):253-61.
1999: David Porter; Joseph H Antin
The graft-versus-leukemia effects of allogeneic cell therapy.
Annual review of medicine 1999;50():369-86.
1998: Donna Przepiorka; G L Phillips; Voravit Ratanatharathorn; M Cottler-Fox; L H Sehn; Joseph H Antin; D LeBherz; Michel Awwad; James Hope; J B McClain
A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease.
Blood 1998;92(11):4066-71.
1998: Stephanie J Lee; C Anasetti; K M Kuntz; J Patten; Joseph H Antin; Jane C Weeks
The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.
Blood 1998;92(11):4047-52.
1998: E Vance; Suzanne George; Eva C Guinan; C Wheeler; Joseph H Antin; Donna M Ambrosino; Deborah C Molrine
Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
Bone marrow transplantation 1998;22(8):735-41.
1998: Voravit Ratanatharathorn; Richard A Nash; Donna Przepiorka; Steven M Devine; Jared L Klein; Daniel Weisdorf; Joseph W Fay; Auayporn Nademanee; Joseph H Antin; Neal Christiansen; R van der Jagt; Roger H Herzig; Mark R Litzow; Steven Neil Wolff; W L Longo; F B Petersen; Chatchada Karanes; Belinda R Avalos; Rainer Storb; Donald N Buell; Rochelle M Maher; William E Fitzsimmons; John R Wingard
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Blood 1998;92(7):2303-14.
1998: S J Lee; C Anasetti; M M Horowitz; Joseph H Antin
Initial therapy for chronic myelogenous leukemia: playing the odds.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2897-903.
1998: MD Kraus; Aliakbar Shahsafaei; Joseph H Antin; Robert D Odze
Relationship of Bcl-2 expression with apoptosis and proliferation in colonic graft versus host disease.
Human pathology 1998;29(8):869-75.
1998: Paul G Richardson; Anthony D Elias; A Krishnan; C Wheeler; R Nath; D Hoppensteadt; N M Kinchla; Donna Neuberg; Edmond WALLER; Joseph H Antin; Robert J Soiffer; James J Vredenburgh; M Lill; A E Woolfrey; Scott I Bearman; M Iacobelli; J Fareed; Eva C Guinan
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.
Blood 1998;92(3):737-44.
1998: Grace Chang; C McGarigle; T R Spitzer; Steven McAfee; F Harris; K Piercy; M N Goetz; Joseph H Antin
A comparison of related and unrelated marrow donors.
Psychosomatic medicine 1998;60(2):163-7.
1998: David Porter; Joseph H Antin
Infusion of donor peripheral blood mononuclear cells to treat relapse after transplantation for chronic myelogenous leukemia.
Hematology/oncology clinics of North America 1998;12(1):123-50.
1998: L H Sehn; Joseph H Antin; Larry N Shulman; Peter M Mauch; A Elias; Marshall E Kadin; C Wheeler
Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.
Blood 1998;91(2):717-23.
1998: Richard J Benjamin; J M Connors; Siobhan McGurk; Winthrop H Churchill; Joseph H Antin
Prolonged erythroid aplasia after major ABO-mismatched transplantation for chronic myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(3):151-6.
1998: MD Kraus; M Feran-Doza; M L Garcia-Moliner; Joseph H Antin; Robert D Odze
Cytomegalovirus infection in the colon of bone marrow transplantation patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(1):29-36.
1998: GW Boswell; Ihor Bekersky; J Fay; John R Wingard; Joseph H Antin; D Weisdorf; Rochelle M Maher; William E Fitzsimmons; R Nash
Tacrolimus pharmacokinetics in BMT patients.
Bone marrow transplantation 1998;21(1):23-8.
1998: Thomas R Ziegler; R L Bye; R L Persinger; L S Young; Joseph H Antin; Douglas W Wilmore
Effects of glutamine supplementation on circulating lymphocytes after bone marrow transplantation: a pilot study.
The American journal of the medical sciences 1998;315(1):4-10.
1997: Sandra Lee; Karen M Kuntz; Mary M Horowitz; Philip B McGlave; J M Goldman; Kathleen A Sobocinski; Janet Hegland; Craig Kollman; Susan K Parsons; Milton C Weinstein; Jane C Weeks; Joseph H Antin
Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.
Annals of internal medicine 1997;127(12):1080-8.
1997: Patrick Y Wen; Edwin P Alyea; D Simon; R S Herbst; Robert J Soiffer; Joseph H Antin
Guillain-Barré syndrome following allogeneic bone marrow transplantation.
Neurology 1997;49(6):1711-4.
1997: K K Ballen; D G Gilliland; Eva C Guinan; C C Hsieh; Susan K Parsons; I J Rimm; James L M Ferrara; BE Bierer; Howard J Weinstein; Joseph H Antin
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.
Bone marrow transplantation 1997;20(9):737-43.
1997: Michael A Andrykowski; Janet S Carpenter; C B Greiner; Elizabeth M Altmaier; T G Burish; Joseph H Antin; Roger Gingrich; Matthew J Cordova; PJ Henslee-Downey
Energy level and sleep quality following bone marrow transplantation.
Bone marrow transplantation 1997;20(8):669-79.
1997: C Y Chan; Deborah C Molrine; Joseph H Antin; C Wheeler; Eva C Guinan; Howard J Weinstein; N R Phillips; Carol McGarigle; S Harvey; CP Schnipper; Donna M Ambrosino
Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).
Bone marrow transplantation 1997;20(1):33-8.
1997: C Wheeler; C Eickhoff; A Elias; Joseph G Ibrahim; Lois Jeanne Ayash; Mary McCauley; Peter M Mauch; Gary Schwartz; Joseph P Eder; R Mazanet; James L M Ferrara; I J Rimm; Eva C Guinan; BE Bierer; G Gilliland; Winthrop H Churchill; K Ault; S Parsons; Karen Antman; Lowell E Schnipper; I Tepler; L Gaynes; Emil Frei; Marshall E Kadin; Joseph H Antin
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):98-106.
1997: D Fountain; M Ralston; N Higgins; J B Gorlin; L Uhl; C Wheeler; Joseph H Antin; Winthrop H Churchill; Richard J Benjamin
Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components.
Transfusion 1997;37(6):585-91.
1997: Grace Chang; Joseph H Antin; E J Orav; U Randall; Carol McGarigle; HM Behr
Substance abuse and bone marrow transplant.
The American journal of drug and alcohol abuse 1997;23(2):301-8.
1997: Stephanie J Lee; S A Wegner; Carol McGarigle; B E Bierer; Joseph H Antin
Treatment of chronic graft-versus-host disease with clofazimine.
Blood 1997;89(7):2298-302.
1997: Robert H Collins; O Shpilberg; William R Drobyski; David Porter; Sergio Giralt; Richard Champlin; Stacey A Goodman; Steven Neil Wolff; W Hu; C Verfaillie; A List; W Dalton; N Ognoskie; A Chetrit; Joseph H Antin; John Nemunaitis
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):433-44.
1997: Stephanie J Lee; Winthrop H Churchill; A Konugres; D G Gilliland; Joseph H Antin
Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation--treatment with anti-D immunoglobulin.
Bone marrow transplantation 1997;19(2):173-4.
1997: David Porter; Joseph H Antin
Graft-versus-leukemia effect of allogeneic bone marrow transplantation and donor mononuclear cell infusions.
Cancer treatment and research 1997;77():57-85.
1997: Richard J Benjamin; L Linsley; D Fountain; Winthrop H Churchill; C Sieff; ME Cannon; L Uhl; L Gaynes; Joseph H Antin; C Wheeler
Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield.
Transfusion 1997;37(1):79-85.
1996: William C Nichols; Joseph H Antin; Kathryn L Lunetta; Valeri Terry; C E Hertel; M A Wheatley; N D Arnold; DR Siemieniak; Michael Boehnke; David Ginsburg
Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease.
Blood 1996;88(12):4429-34.
1996: David Porter; M S Roth; Sandra Lee; Carol McGarigle; James L M Ferrara; Joseph H Antin
Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.
Bone marrow transplantation 1996;18(5):975-80.
1996: Deborah C Molrine; Eva C Guinan; Joseph H Antin; C Wheeler; Susan K Parsons; Howard J Weinstein; Carol McGarigle; P Blanding; N R Phillips; A Ciamarra; Suzanne George; Donna M Ambrosino
Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation.
Bone marrow transplantation 1996;17(6):1149-55.
1996: Sook-Bin Woo; C M Allen; A Orden; David Porter; Joseph H Antin
Non-gingival soft tissue growths after allogeneic marrow transplantation.
Bone marrow transplantation 1996;17(6):1127-32.
1996: Joseph W Fay; John R Wingard; Joseph H Antin; Robert H Collins; L A Piñeiro; B R Blazar; R Saral; B E Bierer; Donna Przepiorka; William E Fitzsimmons; Rochelle M Maher; D J Weisdorf
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation.
Blood 1996;87(8):3514-9.
1996: Deborah C Molrine; Eva C Guinan; Joseph H Antin; Susan K Parsons; Howard J Weinstein; C Wheeler; Carol McGarigle; P Blanding; N R Phillips; K Kinsella; K Deans; A Ciamarra; Allen M Goorin; Suzanne George; Donna M Ambrosino
Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation.
Blood 1996;87(7):3012-8.
1995: Richard B Schwartz; S M Bravo; RA Klufas; Liangge Hsu; Patrick D Barnes; C D Robson; Joseph H Antin
Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.
AJR. American journal of roentgenology 1995;165(3):627-31.
1995: Michael A Andrykowski; C B Greiner; E M Altmaier; T G Burish; Joseph H Antin; Roger Gingrich; Carol McGarigle; PJ Henslee-Downey
Quality of life following bone marrow transplantation: findings from a multicentre study.
British journal of cancer 1995;71(6):1322-9.
1995: David Porter; Joseph H Antin
Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation.
Leukemia & lymphoma 1995;17(3-4):191-7.
1995: Michael A Andrykowski; M J Brady; C B Greiner; E M Altmaier; T G Burish; Joseph H Antin; Roger Gingrich; Carol McGarigle; PJ Henslee-Downey
'Returning to normal' following bone marrow transplantation: outcomes, expectations and informed consent.
Bone marrow transplantation 1995;15(4):573-81.
1995: A J Mitus; Kenneth B Miller; David P Schenkein; H F Ryan; Susan K Parsons; C Wheeler; Joseph H Antin
Improved survival for patients with acute myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):560-9.
1994: S Y Pai; David A Fruman; T Leong; Donna Neuberg; T G Rosano; Carol McGarigle; Joseph H Antin; B E Bierer
Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A.
Blood 1994;84(11):3974-9.
1994: David Porter; G J Orloff; Joseph H Antin
Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.
Transplantation science 1994;4(1):12-4; discussion 14-6.
1994: Joseph H Antin; Howard J Weinstein; Eva C Guinan; P McCarthy; B E Bierer; D Gary Gilliland; Susan K Parsons; K K Ballen; IJ Rimm; G Falzarano
Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.
Blood 1994;84(4):1342-8.
1994: A J Mitus; Joseph H Antin; C J Rutherford; Carol McGarigle; MA Goldberg
Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.
Blood 1994;83(7):1952-7.
1994: Eva C Guinan; Deborah C Molrine; Joseph H Antin; M C Lee; Howard J Weinstein; Stephen E Sallan; Susan K Parsons; C Wheeler; W Gross; Carol McGarigle
Polysaccharide conjugate vaccine responses in bone marrow transplant patients.
Transplantation 1994;57(5):677-84.
1994: David Porter; M S Roth; Carol McGarigle; James L M Ferrara; Joseph H Antin
Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
The New England journal of medicine 1994;330(2):100-6.
1994: Joseph H Antin
Cytokines and graft-V-host disease.
Progress in clinical and biological research 1994;390():193-202.
1993: Joseph H Antin
Graft-versus-leukemia: no longer an epiphenomenon.
Blood 1993;82(8):2273-7.
1993: Larry N Shulman; B Frisard; Joseph H Antin; C Wheeler; G Pinkus; N Magauran; Peter M Mauch; E Nobles; R Mashal; George P Canellos
Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(5):937-42.
1993: K K Ballen; Joseph H Antin
Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
Hematology/oncology clinics of North America 1993;7(2):477-93.
1993: D F Stroncek; P V Holland; G Bartch; T Bixby; RG Simmons; Joseph H Antin; Kenneth C Anderson; R C Ash; B J Bolwell; J A Hansen
Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program.
Blood 1993;81(7):1940-6.
1993: D J Araten; T Lawton; James L M Ferrara; Joseph H Antin; E Milford; Charles B Carpenter; Richard T Maziarz
In vitro alloreactivity against host antigens in an adult HLA-mismatched bone marrow transplant recipient despite in vivo host tolerance.
Transplantation 1993;55(1):76-82.
1992: Joseph H Antin; James L M Ferrara
Cytokine dysregulation and acute graft-versus-host disease.
Blood 1992;80(12):2964-8.
1992: K K Ballen; D Donadio; C Bouloux; P McCarthy; H Weinstein; Joseph H Antin
Herpes simplex virus and neutropenia following bone marrow transplantation.
Transplantation 1992;54(3):553-5.
1992: W Aird; M Labopin; N C Gorin; Joseph H Antin
Long-term cryopreservation of human stem cells.
Bone marrow transplantation 1992;9(6):487-90.
1992: Thomas R Ziegler; L S Young; K Benfell; M Scheltinga; K Hortos; R Bye; F D Morrow; Danny O Jacobs; R J Smith; Joseph H Antin
Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.
Annals of internal medicine 1992;116(10):821-8.
1992: Patrick Y Wen; K L Blanchard; C C Block; Jay S Loeffler; D G Davis; L A Lacroix; Joseph H Antin
Development of Lhermitte's sign after bone marrow transplantation.
Cancer 1992;69(9):2262-6.
1992: Francis D Moore; R M Jack; Joseph H Antin
Peripheral blood neutrophils in chronically neutropenic patients respond to granulocyte-macrophage colony-stimulating factor with a specific increase in CR1 expression and CR1 transcription.
Blood 1992;79(7):1667-71.
1992: M S Roth; Joseph H Antin; R Ash; Valeri Terry; M Gotlieb; Samuel Michael Silver; David Ginsburg
Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia.
Blood 1992;79(1):276-82.
1991: Lynda C Schneider; Joseph H Antin; H Weinstein; J S Abrams; M K Pearce; Raif S Geha; Donata Vercelli
Lymphokine profile in bone marrow transplant recipients.
Blood 1991;78(11):3076-80.
1991: Joseph H Antin; B E Bierer; Brian R Smith; James L M Ferrara; Eva C Guinan; Colin A Sieff; David E Golan; R M Macklis; Nancy J Tarbell; E Lynch
Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.
Blood 1991;78(8):2139-49.
1991: M R Scheltinga; L S Young; K Benfell; R L Bye; Thomas R Ziegler; A A Santos; Joseph H Antin; P R Schloerb; Douglas W Wilmore
Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress.
Annals of surgery 1991;214(4):385-93; discussion 393-5.
1991: A C Braverman; Joseph H Antin; M T Plappert; E F Cook; R T Lee
Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1215-23.
1991: MA Goldberg; C C Gaut; L Schapira; Joseph H Antin; B J Ransil; K H Antman; J P Eder; Carol McGarigle; H Franklin Bunn
Erythropoietin gene regulation: from the laboratory to the bedside.
Contributions to nephrology 1991;88():35-45; discussion 46-7.
1990: L Schapira; Joseph H Antin; B J Ransil; K H Antman; Joseph P Eder; Carol McGarigle; MA Goldberg
Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy.
Blood 1990;76(11):2354-9.
1990: Gregory D Longmore; Eva C Guinan; Howard J Weinstein; Richard D Gelber; J M Rappeport; Joseph H Antin
Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1707-14.
1990: Lois Jeanne Ayash; M Hunt; Karen Antman; Lee M Nadler; C Wheeler; Tak Takvorian; A Elias; Joseph H Antin; T Greenough; Joseph P Eder
Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1699-706.
1990: Joseph H Antin; D S Weinberg; D S Rosenthal
Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia.
Experimental hematology 1990;18(4):266-70.
1990: C Wheeler; Joseph H Antin; W H Churchill; Steven E Come; Brian R Smith; Glenn J Bubley; D S Rosenthal; J M Rappaport; K A Ault; Lowell E Schnipper
Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):648-56.
1990: V S Byers; P J Henslee; Nancy A Kernan; B R Blazar; R Gingrich; G L Phillips; C F LeMaistre; G Gilliland; Joseph H Antin; P Martin
Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease.
Blood 1990;75(7):1426-32.
1990: M S Roth; Joseph H Antin; E L Bingham; David Ginsburg
Use of polymerase chain reaction-detected sequence polymorphisms to document engraftment following allogeneic bone marrow transplantation.
Transplantation 1990;49(4):714-20.
1990: Joseph H Antin; B E Bierer; Brian R Smith; Eva C Guinan; M M Provost; James L M Ferrara; R M Macklis; Nancy J Tarbell; H Blythman; C Bouloux
Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
Progress in clinical and biological research 1990;333():207-15.
1989: A J Mitus; R Stein; J M Rappeport; Joseph H Antin; Howard J Weinstein; Chester A Alper; Brian R Smith
Monoclonal and oligoclonal gammopathy after bone marrow transplantation.
Blood 1989;74(8):2764-8.
1989: M S Roth; Joseph H Antin; E L Bingham; David Ginsburg
Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.
Blood 1989;74(2):882-5.
1989: R E Ibrahim; D Teich; Brian R Smith; Joseph H Antin; A P Olivier; D S Weinberg
Flow cytometric surface light chain analysis of lymphocyte-rich effusions. A useful adjunct to cytologic diagnosis.
Cancer 1989;63(10):2024-9.
1989: S G Emerson; Joseph H Antin
Bone marrow progenitor cells induce a regulatory autologous proliferative T lymphocyte response.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(3):766-72.
1988: B E Bierer; Stephen G Emerson; Joseph H Antin; Richard T Maziarz; J M Rappeport; Brian R Smith; Steven J Burakoff
Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation.
Transplantation 1988;46(6):835-9.
1988: Richard T Maziarz; I Tepler; Joseph H Antin; M A Keroack; Winthrop H Churchill; W Holmes; J Rappeport
Reversal of infection with Mycobacterium avium intracellulare by treatment with alpha-interferon in a patient with hairy cell leukemia.
Annals of internal medicine 1988;109(4):292-4.
1988: Joseph H Antin; Brian R Smith; W Holmes; R N David; S Rosenthal
Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
Behring Institute Mitteilungen 1988;(83):149-53.
1988: Joseph H Antin; Brian R Smith; W Holmes; D S Rosenthal
Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.
Blood 1988;72(2):705-13.
1988: Richard M Stone; M Maguire; M A Goldberg; Joseph H Antin; D S Rosenthal; Robert J Mayer
Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Blood 1988;71(3):690-6.
1987: Joseph H Antin; K A Ault; J M Rappeport; Brian R Smith
B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes.
The Journal of clinical investigation 1987;80(2):325-32.
1986: M A Goldberg; Joseph H Antin; Eva C Guinan; J M Rappeport
Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor.
Blood 1986;68(5):1114-8.
1985: Joseph H Antin; David Ginsburg; Brian R Smith; David G Nathan; Stuart H Orkin; J M Rappeport
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment.
Blood 1985;66(6):1247-50.
1985: David Ginsburg; Joseph H Antin; Brian R Smith; Stuart H Orkin; J M Rappeport
Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms.
The Journal of clinical investigation 1985;75(2):596-603.